
Nov 15 (Reuters) – Johnson & Johnson could announce a deal as soon as Monday to buy Texas-based biotech Ollin Biosciences for up to $3.4 billion, the Financial Times said, citing people familiar with
(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)
‘Slow Horses’ to end with Season 8
Los Angeles [US], November 16 (ANI): 'Slow Horses' is coming to an end with the…
Svitolina to return to Ukraine, vows continued support for war-hit homeland
VIDEO SHOWS: COMMENTS FROM UKRAINIAN ELINA SVITOLINA ON HER PLANS TO RETURN TO UKRAINE COMPLETE…
CHINA STATS BUREAU SPOKESPERSON: CHINA'S STEADY ECONOMIC OPERATIONS HAVE NOT CHANGED INTO Q4
CHINA STATS BUREAU SPOKESPERSON: CHINA'S STEADY ECONOMIC OPERATIONS HAVE NOT CHANGED INTO Q4 (The article…